Suppr超能文献

内镜治疗十二指肠非壶腹浅表肿瘤:欧洲胃肠道内镜学会(ESGE)指南。

Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

机构信息

Department of Digestive Endoscopy, Centre Hospitalier Universitaire de Nice, Nice, France.

Department of Endoscopic Services, Western Health, Melbourne, Australia.

出版信息

Endoscopy. 2021 May;53(5):522-534. doi: 10.1055/a-1442-2395. Epub 2021 Apr 1.

Abstract

1: ESGE recommends that all duodenal adenomas should be considered for endoscopic resection as progression to invasive carcinoma is highly likely.Strong recommendation, low quality evidence. 2: ESGE recommends performance of a colonoscopy, if that has not yet been done, in cases of duodenal adenoma.Strong recommendation, low quality evidence. 3: ESGE recommends the use of the cap-assisted method when the location of the minor and/or major papilla and their relationship to a duodenal adenoma is not clearly established during forward-viewing endoscopy.Strong recommendation, moderate quality evidence. 4: ESGE recommends the routine use of a side-viewing endoscope when a laterally spreading adenoma with extension to the minor and/or major papilla is suspected.Strong recommendation, low quality evidence. 5: ESGE suggests cold snare polypectomy for small (< 6 mm in size) nonmalignant duodenal adenomas.Weak recommendation, low quality evidence. 6: ESGE recommends endoscopic mucosal resection (EMR) as the first-line endoscopic resection technique for nonmalignant large nonampullary duodenal adenomas.Strong recommendation, moderate quality evidence. 7: ESGE recommends that endoscopic submucosal dissection (ESD) for duodenal adenomas is an effective resection technique only in expert hands.Strong recommendation, low quality evidence. 8: ESGE recommends using techniques that minimize adverse events such as immediate or delayed bleeding or perforation. These may include piecemeal resection, defect closure techniques, noncontact hemostasis, and other emerging techniques, and these should be considered on a case-by-case basis.Strong recommendation, low quality evidence. 9: ESGE recommends endoscopic surveillance 3 months after the index treatment. In cases of no recurrence, a further follow-up endoscopy should be done 1 year later. Thereafter, surveillance intervals should be adapted to the lesion site, en bloc resection status, and initial histological result. Strong recommendation, low quality evidence.

摘要
  1. ESGE 建议所有十二指肠腺瘤都应考虑进行内镜切除,因为向浸润性癌进展的可能性很高。强烈推荐,低质量证据。

  2. ESGE 建议在已行十二指肠腺瘤内镜切除的病例中,如果尚未进行结肠镜检查,则行结肠镜检查。强烈推荐,低质量证据。

  3. ESGE 建议在正向内镜检查时不能明确确定小乳头和/或大乳头的位置及其与十二指肠腺瘤的关系时,使用帽辅助法。强烈推荐,中等质量证据。

  4. ESGE 建议在怀疑侧向扩展腺瘤延伸至小乳头和/或大乳头时常规使用侧视内镜。强烈推荐,低质量证据。

  5. ESGE 建议对小(<6mm 大小)非恶性十二指肠腺瘤使用冷圈套息肉切除术。弱推荐,低质量证据。

  6. ESGE 建议内镜黏膜切除术(EMR)作为非恶性大非壶腹十二指肠腺瘤的一线内镜切除技术。强烈推荐,中等质量证据。

  7. ESGE 建议内镜黏膜下剥离术(ESD)仅在专家手中才是十二指肠腺瘤的有效切除技术。强烈推荐,低质量证据。

  8. ESGE 建议使用可最大程度减少不良事件(如即时或延迟出血或穿孔)的技术。这些技术可能包括分片切除、缺损闭合技术、非接触性止血和其他新兴技术,并且应根据具体情况进行考虑。强烈推荐,低质量证据。

  9. ESGE 建议在指数治疗后 3 个月进行内镜监测。在无复发的情况下,应在 1 年后进行进一步的随访内镜检查。此后,监测间隔应根据病变部位、整块切除状态和初始组织学结果进行调整。强烈推荐,低质量证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验